Elijah M Bolotin

Pharmain Corporation

Employers

Pharmain Corporation

Affiliated Awards

Award Title	Agency	Phase	Award amount	Start Date	End Date
Vasoactive Intestinal Peptide for the treatment of Female Sexual Arousal Disorder Pharmain Corporation Principal Investigator	HHS	1	$225K	02/15/14	10/31/14
Vasoactive intestinal peptide for the treatment of psoriasis Pharmain Corporation Principal Investigator	HHS	1	$145K	09/01/13	08/31/14
Nanocarrier formulated enzyme for the treatment of S. aureus infection Pharmain Corporation Principal Investigator	HHS	1	$300K	05/01/13	04/30/14
Vasoactive intestinal peptide for the treatment of psoriasis Pharmain Corporation Principal Investigator	HHS	1	$227K	09/07/12	08/31/13
Nanocarrier formulated enzyme for the treatment of S. aureus infection Pharmain Corporation Principal Investigator	HHS	1	$300K	05/09/12	04/30/13
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR Pharmain Corporation Principal Investigator	HHS	2	$432K	07/01/11	03/31/12
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR Pharmain Corporation Principal Investigator	HHS	2	$351K	07/01/10	06/30/11
Nanocarrier-formulated anti-fibrotic peptides for cirrhosis - Fast Track SBIR Pharmain Corporation Principal Investigator	HHS	2	$160K	04/01/10	06/30/10
Outpatient treatment for portal hypertension Pharmain Corporation Principal Investigator	HHS	1	$223K	03/01/10	03/28/11
Long Acting Native GLP-1 formulations for Type 1 Diabetes Pharmain Corporation Principal Investigator	HHS	2	$116K	03/01/09	02/28/11
Long Acting Native GLP-1 formulations for Type 1 Diabetes Pharmain Corporation Principal Investigator	HHS	2	$959K	03/01/09	02/28/11
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid Pharmain Corporation Principal Investigator	HHS	1	$184K	02/01/09	01/31/10
Long Acting Native GLP-1 formulations for Type 1 Diabetes Pharmain Corporation Principal Investigator	HHS	2	$61.3K	03/01/08	02/28/09
Long Acting Native GLP-1 formulations for Type 1 Diabetes Pharmain Corporation Principal Investigator	HHS	2	$961K	03/01/08	02/28/09
Nanocarrier with metal bridge for affinity based delivery of metal binding peptid Pharmain Corporation Principal Investigator	HHS	1	$200K	02/15/08	01/31/09
Long Acting Native GLP-1 formulations for Type 1 Diabetes Pharmain Corporation Principal Investigator	HHS	2	$915K	03/15/07	02/29/08
Targeted formulations of GLP -1 for Type 1 diabetes Pharmain Corporation Principal Investigator	HHS	1	$500K	09/01/05	08/31/06
Targeted formulations of GLP -1 for Type 1 diabetes Pharmain Corporation Principal Investigator	HHS	1	$501K	09/30/04	08/31/05